Johnson & Johnson to partner with Merck to produce COVID-19 vaccine doses

Mar 02, 2021 - 03:02 PM
White House image

President Biden today announced a major partnership between Johnson & Johnson and Merck to manufacture the latest COVID-19 vaccine to be authorized for emergency use in the U.S.

The arrangement includes activating the Defense Production Act to help equip two Merck facilities to produce the Johnson & Johnson vaccine, including a fill-finish facility to fill vials and package shots for distribution. The other facility will produce the vaccine itself.

The arrangement is expected to boost lagging Johnson & Johnson supply issues, which will fall significantly short of an initial goal of delivering 12 million shots by the end of February. Instead, Johnson & Johnson, whose vaccine earned a Food and Drug Administration emergency use authorization over the weekend, revised its expectations to 20 million does by the end of March, and 100 million by June.

Related News Articles

Headline
Study estimates more than 155,000 uncounted COVID-19 deaths occurred early during pandemic 
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…